Last reviewed · How we verify

NCT03962946: RaDiX

Distal Radius Fracture: Clinical Outcome After Conservative Treatment in the Elder Patient

Completed Last updated 24 May 2019
What this trial tests

trial testing Questionnaires to assess Patient reported Outcomes in Distal Radius Fracture in 100 participants. Completed in 18 October 2018.

Timeline
17 April 2018
Primary endpoint
18 October 2018
18 October 2018

Quick facts

Lead sponsorUniversity Hospital, Basel, Switzerland
StatusCompleted
Study typeOBSERVATIONAL
Enrollment100
Start date17 April 2018
Primary completion18 October 2018
Estimated completion18 October 2018
Sites1 location across Switzerland

Drugs / interventions tested

Conditions studied

Sponsor

University Hospital, Basel, Switzerland

Who can join

65 and older, any sex, with Distal Radius Fracture. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study is performed to evaluate the outcome of conservative treatment after distal radius fractures in patients of 65 years or older at the time of the injury, primarily with respect to the prognostic value of the Adolfsson-score for the functional demands of the patient on his hand.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Distal Radius Fracture

Currently open trials in the same condition.

Other University Hospital, Basel, Switzerland trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03962946.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing